Dyno Therapeutics and Trisk Bio partner for strategic manufacture
Announced in May 2025, the Dyno Frontiers Program helps gene therapy innovators prove the therapeutic potential of their genetic medicines.
Partners
Low concentrations are no obstacle to detection in gas chromatography analysis
The latest regulatory updates affecting parenteral packaging
Podcast: Managing complexities and challenges in early-phase clinical trials
Turning bottlenecks into breakthroughs in gene therapy manufacturing
Remote monitoring: The tech enhancing diabetes management in Scotland
The future of high-potency APIs: Strategies for manufacturing challenges
Oximio welcomes Canada’s Bay Area Research Logistics to expand global reach and services
